These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10036815)

  • 1. Current management and future trends in benign prostatic hyperplasia (BPH).
    Fitzpatrick JM
    Ir Med J; 1997 Nov; 90(7):256, 258. PubMed ID: 10036815
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 4. Benign prostatic hyperplasia (BPH).
    Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
    Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G
    J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
    Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
    J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
    Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
    Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride for BPH.
    Johnson KH; Casey CM
    J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of benign prostatic hypertrophy].
    Romics I
    Orv Hetil; 2003 Nov; 144(45):2229-30. PubMed ID: 14686009
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
    Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
    BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia. Age and type of treatment.
    Bono AV; Fava C
    J Urol (Paris); 1995; 101(1):50-2. PubMed ID: 7545731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
    Mazo EB
    Urologiia; 2001; (3):20-2. PubMed ID: 11505535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
    Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
    Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hypertrophy.
    Geller J
    Curr Ther Endocrinol Metab; 1997; 6():586-93. PubMed ID: 9174812
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting therapy for maintaining sexual function in patients with benign prostatic hyperplasia.
    Nehra A
    BJU Int; 2005 Aug; 96(3):237-43. PubMed ID: 16042709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.